-+ 0.00%
-+ 0.00%
-+ 0.00%

TVARDI THERAPEUTICS INC - TOPLINE DATA FROM REVERT IPF TRIAL EXPECTED IN Q4 2025

Reuters·05/27/2025 12:00:03

Please log in to view news